Home / Innere Medizin / Onkologie / Dr. Suresh Ramalingam presents the results of the FLAURA study

Dr. Suresh Ramalingam presents the results of the FLAURA study

Dr. Suresh Ramalingam presents the results of the FLAURA study (presidental symposium): Osimertinib vs standard of care (SoC) EGFR-TKI as first-line therapy in patients (pts) with EGFRm advanced NSCLC.

Interviewpartner:

Redaktion:

Produktion:

 

LOGIN

Login

Passwort vergessen?